Conditions: Herpes Simplex
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 275
Healthy volunteers: no

Brief summary:
A multicenter, open-label study is conducted to evaluate the efficacy and safety of ASP2151 in patients with herpes simplex (recurrent labial/facial herpes and recurrent genital herpes and Kaposi varicelliform).

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: ASP2151
Intervention descriptions: intervention 1: None

Protocol document: